APYP News and Press, Appyea Inc From 11/29/22

In the first phase, DreamIT will be available to Android users and delivery of the first devices to customers is expected by the end of the year. GAN YAVNE, ISRAEL / ACCESSWIRE / November 29, 2022 / SleepX, a subsidiary of AppYea Inc. (OTC:APYP) , which focuses on the d...

--News Direct-- SleepX, a subsidiary of AppYea (OTC: APYPD) focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, announces it has applied to the Helsinki Committee for approval to begin its planned clinical trial on the SleepX PRO a...

--News Direct-- World renowned machine learning and bio-feedback expert joins company to execute and lead the development of DreamIT – the company’s patented solution integrating its proprietary AI technology in a wearable data driven wristband to treat sleep apnea and s...

--News Direct-- AppYea (OTC: APYP) , a medical device technology company, announced today the deemed completion of its previously announced acquisiiton of SleepX, an innovative medical device company focused on the development of SleepX’s flagship product DreamIT – an ...

--News Direct-- Provides the following letter to its shareholders from its Chairman Boris Molchadsky: "I am pleased with the progress AppYea/SleepX has been making this year. As part of the long terms objective, AppYea Inc. (OTCPINK: APYP) took the initial step to advance the prospe...

--News Direct-- AppYea continues the process of merging SleepX into the company. The merger is expected to be completed by 12/01/2021 in accordance with the model published on 08/02/2021 ( Link ) In parallel, SleepX continues developing and improving its algorithms and planning ...

There’s one thing that doesn’t change regardless of monetary policy, economic cyclicality, politics, technicals, or even pandemics: everyone sleeps a third of their life. That adds up to over 23 trillion hours of sleeping happening by human consumers every year. Companies able t...

The global sleep apnea devices market size was valued at USD 3.7 billion in 2020 and is expected to expand at a compound annual growth rate of 6.2% from 2021 to 2028. Sleep apnea is a sleeping disorder, characterized by irregular breathing, thus providing insufficient oxygen to the brain. Acc...

Fort Worth, Texas, Feb. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AppYea, Inc. (OTCPK:APYP, or the "Company"), announced today that the company has engaged Smalltell (Smalltell.com) to develop a new website and marketing strategy for its new CBD based line of products.  Smalltel...

Fort Worth, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AppYea, Inc. (OTCPK:APYP, or the "Company"), which previously announced its move into Hemp based CBD infused products, announced today that the company has received and fulfilled its first purchase order from Hempori, ...